Welcome to Rosalm Franklin University College of Pharmacy Top 200 Drugs podcast.

This podcast is produced by the pharmacy faculty members to supplement study material for students learning the top 200 drugs.

We're hoping that our real-life clinical

pearls and discussions from practicing pharmacists will help you study for your next drug quiz.

I know participants have any conflicts of interest to disclose. This podcast is for educational purposes

only and is not intended to treat a particular patient. This information should

not be used in lieu of the judgment of a health care provider. This podcast is copyright, Rosalind Franklin

University of Medicine and Science. And now on to the show. Welcome to the week eight, Rosalind Franklin

University Top 200 Dr. Dr. Cain her co-host, Dr. Kane.

I'm Dr. Weatherton.

And I'm Dr. Patel.

And this week, we're going to be talking about non-steroidal anti-inflammatory drugs or

insides, which are used very commonly, both over-the-counter and prescription.

The agents we'll be talking about today are the prescription agents.

Dr. Patel, is there anything that's common to all of these prescription agents?

Yes, actually, a lot of these medications, especially the prescription medication, have common labeling.

And some of the common characteristics would be such as a black box warning that applies to most of the prescription endsides,

and that is increased risk of cardiovascular, thrombotic events such as a heart attack or stroke,

and GI side effects such as GI ulceration, bleeding, or even worse, fatal perforation.

That sounds horrible. Why would anyone want to take any of these medications?

Well, because they work. They do a great job at relieving pain and inflammation. And some of the

other common characteristic we need to think about is that these medications are contraindicated

...